Stratec (ETR:SBS) Stock Price Up 0.4% - Should You Buy?

Key Points

• Stratec SE shares increased by 0.4%, closing at €26.85 ($31.22) after trading as high as €27.15 ($31.57) during the day.
• The company has a market capitalization of $326.77 million and a P/E ratio of 32.64, indicating its earnings relative to its share price.
• Stratec designs and manufactures automation and instrumentation solutions for in-vitro diagnostics and life sciences, serving both domestic and international markets.

Stratec SE (ETR:SBS - ) shares rose 0.4% during mid-day trading on Tuesday . The company traded as high as €27.15 ($31.57) and last traded at €26.85 ($31.22). Approximately 3,368 shares traded hands during trading, a decline of 46% from the average daily volume of 6,253 shares. The stock had previously closed at €26.75 ($31.10).

Stratec Stock Up 1.3%

The business has a 50-day moving average price of €26.80 and a 200-day moving average price of €27.42. The company has a current ratio of 2.52, a quick ratio of 1.65 and a debt-to-equity ratio of 66.97. The firm has a market cap of $326.77 million, a P/E ratio of 32.64, a P/E/G ratio of 10.43 and a beta of 0.16.

About Stratec

Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers; and offers complex consumables for diagnostics and medical applications.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.